The DOI matches its Crossref record.
Selective, covalent modification of β-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors
Open accessAbstract
Microtubules are linear polymers of α- and β-tubulin heterodimers and are the major constituents of mitotic spindles, which are essential for the separation of chromosomes during mitosis. Here we describe a synthetic compound, 2-fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene (T138067), which covalently and selectively modifies the β 1 , β 2 , and β 4 isotypes of β-tubulin at a conserved cysteine residue, thereby disrupting microtubule polymerization. Cells exposed to T138067 become altered in shape, indicating a collapse of the cytoskeleton, and show an increase in chromosomal ploidy. Subsequently, these cells undergo apoptosis. Furthermore, T138067 exhibits cytotoxicity against tumor cell lines that exhibit substantial resistance to vinblastine, paclitaxel, doxorubicin, and actinomycin D. T138067 is also equally efficacious in inhibiting the growth of sensitive and multidrug-resistant human tumor xenografts in athymic nude mice. These observations suggest that T138067 may be clinically useful for the treatment of multidrug-resistant tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
Self-citationFluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments
Kirk, K. L. (2008) · Organic Process Research & Development · doi:10.1021/op700134j · Cited by 1,151
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Johnson, B. M., Shu, Y.-Z., Zhuo, X., & Meanwell, N. A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01877 · Cited by 719
An overview of tubulin inhibitors that interact with the colchicine binding site
Lu, Y., Chen, J., Xiao, M., Li, W., & Miller, D. D. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0828-z · Cited by 709
A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Musa, M., Cooperwood, J., & Khan, M. O. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242877 · Cited by 538
Cortical Constriction During Abscission Involves Helices of ESCRT-III–Dependent Filaments
Guizetti, J., Schermelleh, L., Mäntler, J., Maar, S., Poser, I., Leonhardt, H., Müller-Reichert, T., & Gerlich, D. W. (2011) · Science · doi:10.1126/science.1201847 · Cited by 479
Indole, a core nucleus for potent inhibitors of tubulin polymerization
Brancale, A., & Silvestri, R. (2007) · Medicinal Research Reviews · doi:10.1002/med.20080 · Cited by 344
Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance
Zhou, S., Chan, E., Duan, W., Huang, M., & Chen, Y.-Z. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-200028812 · Cited by 274
Variations in the colchicine-binding domain provide insight into the structural switch of tubulin
Dorléans, A., Gigant, B., Ravelli, R. B. G., Mailliet, P., Mikol, V., & Knossow, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904223106 · Cited by 274
Hamel, E. (2003) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:38:1:1 · Cited by 272
Systemic Therapy of Advanced Hepatocellular Carcinoma: How Hopeful Should We Be?
Zhu, A. X. (2006) · The Oncologist · doi:10.1634/theoncologist.11-7-790 · Cited by 260
An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently
Viaud, J., & Peterson, J. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0102 · Cited by 104
Allicin inhibits cell polarization, migration and division via its direct effect on microtubules
Prager‐Khoutorsky, M., Goncharov, I., Rabinkov, A., Mirelman, D., Geiger, B., & Bershadsky, A. D. (2007) · Cell Motility · doi:10.1002/cm.20185 · Cited by 64
Ball, D. P., Lewis, A. M., Williams, D., Resetca, D., Wilson, D. J., & Gunning, P. T. (2016) · Oncotarget · doi:10.18632/oncotarget.7838 · Cited by 50
“SH-4-054 and BP1-102, containing the nucleophilic aromatic substitutionsusceptible pentafluorobenzene sulfonamide substituent [22–25], exhibited reaction half lives (t1/2) of 1.”
Background
Metadata
- Authors
- Shan, B., Medina, J. C., Santha, E., Frankmoelle, W. P., Chou, T.-C., Learned, R. M., Narbut, M. R., Stott, D., Wu, P., Jaen, J. C., Rosen, T., Timmermans, P. B. M. W. M., & Beckmann, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-05-11
- Volume
- 96
- Issue
- 10
- Pages
- 5686-5691
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2101600612
- Cited by
- 164
- References
- 0
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.